Eurya japonica
Eurya japonica · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Eurya japonica is a versatile plant species that has garnered significant scientific interest due to its diverse pharmacological properties. Research has highlighted the medicinal potential of its leaves, which serve as a rich source of bioactive compounds. These extracts have demonstrated promising activities, including antibacterial, anticancer, and anti-HIV effects. Furthermore, the plant exhibits anthelmintic properties and plays a role in regulating biological processes such as angiogenesis. This makes Eurya japonica a subject of great importance in the ongoing search for novel therapeutic agents.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Pentaphylacaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Eurya japonica is a versatile evergreen shrub known by a diverse array of names across different languages and cultures. In English-speaking regions, it is frequently referred to as the Japanese Eurya, while in Russian, it is identified as Эврия японская. Its presence in East Asian gardens is often marked by its Japanese name, ヒサカキ, a term that highlights its cultural significance. The plant also carries unique regional identifiers, such as the Arabic designation يوريا جابونيكا. In certain South Indian contexts, it is locally recognized by the name കാട്ടുതേയില, demonstrating its widespread linguistic reach.
Sources: Catalogue of Life (COL)
Taxonomy
Eurya japonica is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It falls into the order Ericales, showcasing its specific evolutionary lineage. The plant is a member of the Pentaphylacaceae family, which helps define its unique biological characteristics. Ultimately, it is categorized under the genus Eurya, marking its distinct place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Pentaphylacaceae |
| Genus | Eurya |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Eurya japonica is a versatile plant species with a broad distribution spanning across various regions of Asia. In temperate zones, it is commonly found throughout China, particularly in the southeast, as well as across the Korean Peninsula. Its presence is also well-documented in Eastern Asia, specifically within Japan and the Nansei-shoto islands. Beyond these temperate climates, the species extends its reach into tropical environments. This wider range includes the Indo-China region, where it can be found growing in Vietnam.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Eurya japonica is characterized by its distinct growth form as a tree. This species remains self-supporting, maintaining a sturdy and upright structure as it develops.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Eurya japonica leaves possess significant antiangiogenic properties that were identified through a modified chicken-chorioallantoic-membrane assay. This plant was one of several medicinal species found to inhibit angiogenesis by more than 50% in quail eggs. The research suggests that its extracts work through multifactorial modes of action, potentially involving the inhibition of vascular endothelial growth factor receptors. Because of this ability to treat angiogenesis, the plant holds promise for managing conditions where blood vessel formation must be suppressed. Such applications include potential therapeutic uses for cancer, macular degeneration, and diabetic retinopathy.
Preparations
Parts used
Eurya japonica leaves were identified as one of the key botanical sources investigated for their potent antiangiogenic properties. During the study, researchers utilized a modified chicken-chorioallantoic-membrane assay to test the effectiveness of various plant extracts. The results demonstrated that the leaf extracts from this specific plant were able to inhibit angiogenesis by more than 50% in quail eggs. This significant biological activity suggests that the phytochemicals found within the leaves could play a vital role in medicinal applications. Ultimately, such findings highlight the potential use of these natural products in treating diseases like cancer and macular degeneration.